Navigation Links
Pittsburgh Life Sciences Greenhouse Demonstrates a Region's Economic Resilience
Date:9/23/2009

PITTSBURGH, Sept. 23 /PRNewswire/ -- As the world converges on Pittsburgh and Western Pennsylvania, the first thing the international visitors notice are clear skies and the lack of the traditional, stereotypical images of smokestacks lining the city's three rivers. Instead, they are greeted by a region that for the past two decades has successfully transformed itself from a manufacturing economy to a service economy centered on the development and commercialization of advanced technologies, energy and the life sciences.

A cornerstone to this evolutionary process and visible evidence of the region's economic makeover has been the Pittsburgh Life Sciences Greenhouse (PLSG), which in a brief few years has worked with nearly 300 companies and has committed 121 direct investments in 60 companies, totaling $14.7 million. But the larger story is that those direct investments have already been leveraged into $500 million in additional capital fueling regional economic growth. In the past year alone, 10 percent of PLSG portfolio companies have raised $50 million, and another 10 percent are actively seeking a collective $20 million.

"One of the major reasons President Obama selected Pittsburgh to host the G-20 was to showcase to world leaders a strong example of the new economy," said John W. Manzetti, PLSG President & Chief Executive Officer. "Pittsburgh's story is all about possibilities. And a critical component to the story of the region's economic resurgence has been the role the life sciences and biotechnology have played in driving capital investment and employment growth."

Since its formation in 2002, the PLSG has existed to provide capital investments and customized company formation and business growth programs to western Pennsylvania's life sciences enterprises. The organization has propelled the growth of western Pennsylvania's life sciences economy with a focus on investment in the commercialization of promising life sciences technologies.

Summary of PLSG Accomplishments to Date:

  • The PLSG has invested $14.7 million directly into 60 companies to help leverage over $500 million in additional capital.
  • The PLSG has assisted nearly 300 clients/companies through its Executive-in-Residence program.
  • The PLSG has invested $15.2 million in venture capital funds to help leverage an additional $110 million in total funding.
  • The PLSG's SBIR Advance program has assisted nearly 100 companies with their federal grant strategies. To date, these companies have received over $18 million in federal grant funding.
  • The PLSG has provided 27 early stage companies and venture capital and life sciences organizations with office and laboratory space in its incubator.
  • The PLSG has assisted 13 life sciences companies with relocating to the region and is working with other companies to establish operations in western Pennsylvania.
  • The PLSG has leveraged $2.4 million in federal grant money to help provide core and customized workforce training to over 6,000 trainees since September, 2005.
  • The PLSG has helped create 5,000 jobs directly/indirectly including university faculty and facilities. (300+ jobs created in invested companies and 1,000+ jobs in PLSG active companies/clients)
  • 30 executives have participated in the PLSG EIR program: 7 are currently active with PLSG and 20 former EIRs remain in the region.
  • The regional life sciences company formation rate has increased from 2-3 per year to 15-20 new companies per year.

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The Pittsburgh Life Sciences Greenhouse (PLSG) provides capital investments and customized company formation and business growth services to western Pennsylvania's life sciences enterprises. The PLSG supports biosciences companies with promising innovations in the following concentrations: Biotechnology Tools, Diagnostics, Healthcare IT, Medical Devices and Therapeutics. The PLSG is propelling the sustainable growth of the region's life sciences economy by accelerating research and technology commercialization with seed and early-stage companies; connecting investors with their Investment Portfolio companies; expanding established life sciences ventures and relocating biomedical companies to Pennsylvania. For more information, visit www.plsg.com .


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. The Pittsburgh Life Sciences Greenhouse Starts 2009 With Investment Momentum
2. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
3. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
4. Opening Dedication of the New John G. Rangos Sr. Research Center at the New Childrens Hospital of Pittsburgh of UPMC Campus in Lawrenceville
5. Pittsburgh Technology Council Announces Technology 50
6. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
7. Pittsburgh Region Middle School Students Participate in Hands-on Tissue Engineering Summer Camp
8. Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
9. The Pittsburgh Life Sciences Greenhouse Tops $10M in Company Investments
10. The Pittsburgh Life Sciences Greenhouse Invests $100,000 in ParentPlus
11. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):